Vera plunges as Otsuka updates on rival therapy
Source: SeekingAlpha
2025-02-14 14:33:23 ET
More on Otsuka Holdings Co., Ltd., Otsuka Holdings Co., Ltd., etc.
- Vera Therapeutics: Strong Data In IgAN, But We May Be Too Late
- Vera started at buy by Goldman Sachs, atacicept potential cited
- Historical earnings data for Otsuka Holdings Co., Ltd.
- Dividend scorecard for Otsuka Holdings Co., Ltd.
- Financial information for Otsuka Holdings Co., Ltd.
Read the full article on Seeking Alpha
For further details see:
Vera plunges as Otsuka updates on rival therapy
Vera Therapeutics Inc.
NASDAQ: VERA
VERA Trading
9.27% G/L:
$42.67 Last:
1,185,351 Volume:
$40.50 Open:
VERA Latest News
February 26, 2026 07:30:00 am
Vera Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
VERA Stock Data
$3,391,267,270
64,525,817
0.5%
66
N/A
Biotechnology & Life Sciences
Healthcare
US
Brisbane
